These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 3001383)
21. [Hormone therapy of breast carcinoma in men]. Doberauer C; Niederle N Dtsch Med Wochenschr; 1990 Nov; 115(46):1762-8. PubMed ID: 2171893 [No Abstract] [Full Text] [Related]
22. [Immunohistochemical detection of nuclear estrogen receptors with monoclonal antibodies in different types of breast cancer]. Stegner HE; Jonat W; Maass H Pathologe; 1986 May; 7(3):156-63. PubMed ID: 3012503 [No Abstract] [Full Text] [Related]
23. [Anti-hormonal therapy in breast cancer]. Ecker-Schlipf B Med Monatsschr Pharm; 1994 Aug; 17(8):247-50. PubMed ID: 7935152 [No Abstract] [Full Text] [Related]
24. [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay]. Mauriac L; Wafflart J; Trojani M; Durand M Bull Cancer; 1983; 70(3):160-4. PubMed ID: 6309290 [TBL] [Abstract][Full Text] [Related]
25. [Hormone receptors and precancerous lesions of the breast]. Mignot L; Espie M; de Roquancourt A; Gorins A Pathol Biol (Paris); 1983 Nov; 31(9):761-4. PubMed ID: 6318180 [TBL] [Abstract][Full Text] [Related]
26. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches. Hoffmann J; Sommer A J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262 [TBL] [Abstract][Full Text] [Related]
27. Steroid receptors in breast cancer. Desombre ER Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047 [TBL] [Abstract][Full Text] [Related]
28. [Current approaches to hormonal therapy of breast cancer in men]. Letiagin VP; Makarenko NP; Koposova TL Ter Arkh; 1984; 56(9):122-4. PubMed ID: 6096980 [TBL] [Abstract][Full Text] [Related]
29. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients. Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809 [TBL] [Abstract][Full Text] [Related]
30. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer]. Remmele W; Schicketanz KH Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846 [No Abstract] [Full Text] [Related]
31. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B; J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359 [TBL] [Abstract][Full Text] [Related]
32. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984 [TBL] [Abstract][Full Text] [Related]
33. [Morphologic and morphometric parameters of infiltrating duct carcinoma of the breast and receptor state in fluorescence: correlations in 104 cases (1983 case survey)]. Tunesi G; Anselmi L; Bandelloni R; Gambini C; Reale A; Sementa AR; Bronzini E Pathologica; 1985; 77(1049):251-8. PubMed ID: 3008066 [No Abstract] [Full Text] [Related]
34. Hormone receptors in breast cancer and response to chemotherapy. Kaufmann M; Klinga K; Runnebaum B; Kubli F N Engl J Med; 1979 May; 300(18):1052. PubMed ID: 219332 [No Abstract] [Full Text] [Related]
35. [Stability of steroid receptors from breast tumors at different storage temperatures]. Locher GW; Burger H; Davis BW; Zava DT Pathologe; 1984 Mar; 5(2):82-5. PubMed ID: 6326078 [No Abstract] [Full Text] [Related]
36. An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer. Allegra JC; Lippman ME; Thompson EB; Simon R Cancer Res; 1978 Nov; 38(11 Pt 2):4299-304. PubMed ID: 698970 [No Abstract] [Full Text] [Related]
37. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976 [TBL] [Abstract][Full Text] [Related]
38. Steroid receptors in breast cancer. Drafta D Endocrinologie; 1980; 18(2):117-21. PubMed ID: 7384734 [No Abstract] [Full Text] [Related]
39. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients. Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159 [TBL] [Abstract][Full Text] [Related]
40. Hormone receptor modulation in xenotransplanted endocrine related human breast cancer. Michel RT; Vering A; Fortmeyer HP; Stegmüller M Strahlenther Onkol; 1989 Jul; 165(7):497-8. PubMed ID: 2749477 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]